| scholarly article | Q13442814 |
| P2093 | author name string | Howard S Smith | |
| Intikhab Mohsin | |||
| P2860 | cites work | Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2 | Q78710366 |
| Zoledronic acid palliation in bone-metastatic breast cancer | Q79352114 | ||
| The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies | Q83365973 | ||
| Activation of spinal TDAG8 and its downstream PKA signaling pathway contribute to bone cancer pain in rats | Q83929418 | ||
| Music interventions for improving psychological and physical outcomes in cancer patients | Q24234941 | ||
| Radioisotopes for metastatic bone pain | Q24235589 | ||
| NSAIDS or paracetamol, alone or combined with opioids, for cancer pain | Q24246917 | ||
| Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification | Q24600356 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Targeted disruption of the Cl-/HCO3- exchanger Ae2 results in osteopetrosis in mice | Q24658114 | ||
| Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis | Q28140437 | ||
| Nociceptors of dorsal root ganglion express proton-sensing G-protein-coupled receptors | Q28242261 | ||
| Radioisotopes for the palliation of metastatic bone cancer: a systematic review | Q28253672 | ||
| G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers | Q28268833 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metast | Q33353019 | ||
| Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain | Q33373585 | ||
| Image-guided palliation of painful metastases using percutaneous ablation | Q34008639 | ||
| Effect of bisphosphonates on pain and quality of life in patients with bone metastases | Q34015944 | ||
| Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. | Q34149093 | ||
| Malignant bone pain: pathophysiology and treatment | Q34418896 | ||
| Single fraction external beam radiation therapy in the treatment of localized metastatic bone pain. A review | Q34459859 | ||
| Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. | Q34559758 | ||
| American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma | Q34803386 | ||
| Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. | Q35062543 | ||
| Percutaneous vertebroplasty: indications, contraindications, and technique | Q35069461 | ||
| Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. | Q35083626 | ||
| Palliation of Metastatic Bone Pain: Single Fraction versus Multifraction Radiotherapy – A Systematic Review of Randomised Trials | Q35549679 | ||
| The pathophysiology of cancer-induced bone pain: current understanding | Q35805721 | ||
| Radiopharmaceuticals for palliation of painful osseous metastases | Q35865067 | ||
| Breakthrough pain: characteristics and impact in patients with cancer pain. | Q51089873 | ||
| High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. | Q54049336 | ||
| Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis | Q72880158 | ||
| Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal | Q73107714 | ||
| Samarium-153 lexidronam for painful bone metastases | Q73671854 | ||
| Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline | Q74327863 | ||
| Advances in cancer pain management | Q74594833 | ||
| Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain | Q77211813 | ||
| Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival | Q78290738 | ||
| The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief | Q39527376 | ||
| Naproxen sodium in treatment of bone pain due to metastatic cancer | Q39529544 | ||
| The combination of ibuprofen and oxycodone/acetaminophen in the management of chronic cancer pain | Q39529814 | ||
| Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study | Q39548523 | ||
| Injectable Ketoprofen VS. Acetylsalicylic Acid for the Relief of Severe Cancer Pain: A Double-Blind, Crossover Trial | Q39554671 | ||
| The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group | Q39562742 | ||
| Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice | Q39591640 | ||
| Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial | Q39722888 | ||
| Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. | Q39829396 | ||
| Characterization of cancer-induced bone pain: an exploratory study. | Q39850994 | ||
| Cancer pain: progress since the WHO guidelines | Q40265384 | ||
| Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. | Q40477180 | ||
| Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model | Q40538169 | ||
| Tissue acidosis in nociception and pain | Q41330803 | ||
| Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients | Q42475572 | ||
| Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients | Q42516923 | ||
| Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats | Q42923060 | ||
| The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. | Q43842252 | ||
| A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases | Q44291815 | ||
| Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group | Q44978609 | ||
| Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases | Q46098015 | ||
| Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone | Q46266007 | ||
| Oxycodone-induced analgesic effects in a bone cancer pain model in mice | Q46402976 | ||
| Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain | Q46427425 | ||
| Gabapentin for breakthrough pain due to bone metastases. | Q46549450 | ||
| Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro. | Q46646901 | ||
| The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers. | Q46832072 | ||
| Clinical development of anti-RANKL therapy | Q35901092 | ||
| Radionuclide therapy of intractable bone pain: emphasis on strontium-89 | Q36129756 | ||
| Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors | Q36192974 | ||
| Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border | Q36213974 | ||
| The role of c-Src kinase in the regulation of osteoclast function | Q36457934 | ||
| Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists | Q36558056 | ||
| Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines | Q36571974 | ||
| Zoledronic acid in the management of metastatic bone disease. | Q36708315 | ||
| Prevalence of pain in patients with cancer: a systematic review of the past 40 years | Q36758835 | ||
| Palliative radiotherapy trials for bone metastases: a systematic review | Q36784842 | ||
| Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice | Q36791739 | ||
| Translational medicine: cancer pain mechanisms and management | Q37168785 | ||
| Expression and function of proton-sensing G-protein-coupled receptors in inflammatory pain | Q37276630 | ||
| Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. | Q37366851 | ||
| V-ATPase inhibitors and implication in cancer treatment. | Q37598445 | ||
| Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain | Q37683827 | ||
| Percutaneous vertebroplasty for pain management in malignant fractures of the spine with epidural involvement. | Q37696893 | ||
| Treatment of painful bone metastases | Q37710370 | ||
| Intravenous morphine for management of cancer pain | Q37740515 | ||
| Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions | Q37785505 | ||
| Pain management in spinal metastases: the role of percutaneous vertebral augmentation | Q37802107 | ||
| Percutaneous vertebral augmentation in metastatic disease: state of the art. | Q37861657 | ||
| Kyphoplasty for the treatment of malignant vertebral compression fractures caused by metastases | Q37867246 | ||
| Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel | Q37965868 | ||
| A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. | Q38756878 | ||
| Thermal ablation of painful bone metastases | Q39262487 | ||
| Palliative radiotherapy for bone metastases in the last 3 months of life: worthwhile or futile? | Q39264481 | ||
| Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain | Q39265830 | ||
| A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases | Q39266773 | ||
| Time course of pain relief in patients treated with radiotherapy for cancer pain: a prospective study | Q39293967 | ||
| P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain | Q39393829 | ||
| Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate. | Q39401991 | ||
| Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology | Q39415446 | ||
| Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study | Q39471539 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 223-241 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | The Korean journal of pain | Q26842123 |
| P1476 | title | Painful boney metastases | |
| P478 | volume | 26 |
| Q50019533 | Extraspinal Percutaneous Osteoplasty for the Treatment of Painful Bony Metastasis |
| Q49981099 | Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing |
| Q41894451 | Radiofrequency thermal ablation in painful myeloma of the clavicle |
| Q92354755 | Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain |
| Q42391488 | Tageted bipolar radiofrequency decompression with vertebroplasty for intractable radicular pain due to spinal metastasis: a case report |
| Q92803447 | Tumor Necrosis Factor-α Produced by Osteoclasts Might Induce Intractable Pain in a Rat Spinal Metastasis Model of Breast Cancer |
Search more.